Lixisenatide as add-on therapy to basal insulin in type 2 diabetes
Lixisenatide as add-on therapy to basal insulin in type 2 diabetes
- CN 103,717,232 A
- Filed: 05/11/2012
- Published: 04/09/2014
- Est. Priority Date: 05/13/2011
- Status: Active Application